Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats

Endocrinology

Volumn 145, Issue 10, 2004, Pages 4645-4652

  Tang Christensen, Mads ^a   Vrang, Niels ^a   Ortmann, Sylvia ^b,f   Bidlingmaier, Martin ^c   Horvath, Tamas L ^d   Tschöp, Matthias ^e,f  

^a Rheoscience A/S   (Denmark)

^b LEIBNIZ INSTITUTE FOR ZOO AND WILDLIFE RESEARCH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; APPETITE STIMULANT; GHRELIN; NEUROPEPTIDE Y; RECOMBINANT HORMONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEEDING BEHAVIOR; FOOD INTAKE; HUNGER; LOCOMOTION; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; TASTE AVERSION;

ANIMALS; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEEDING BEHAVIOR; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TASTE;

EID: 4644274876     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0529     Document Type: Article

References (41)

1. Wing RR, Goldstein MG, Acton KJ, Birch LL, Jakicic JM, Sallis Jr JF, Smith-West D, Jeffery RW, Surwit RS 2001 Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 24:117-123
2. Yanovski SZ, Yanovski JA 2002 Obesity. N Engl J Med 346:591-602
3. Woods SC, Schwartz MW, Baskin DG, Seeley RJ 2000 Food intake and the regulation of body weight. Annu Rev Psychol 51:255-277
4. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
5. Larsen PJ, Tang-Christensen M, Vrang N 2002 New therapeutic developments in the regulation of food intake by neuropeptides. Ann Endocrinol (Paris) 63:171-175
6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
7. Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
8. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR 2001 Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547
9. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
10. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C 2001 Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24:RC19-RC21
11. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719
12. Hewson AK, Tung LY, Connell DW, Tookman L, Dickson SL 2002 The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic. Diabetes 51:3412-3419
13. Traebert M, Riediger T, Whitebread S, Scharrer E, Schmid HA 2002 Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus. J Neuroendocrinol 14:580-586
14. Seoane LM, Lopez M, Tovar S, Casanueva FF, Senaris R, Dieguez C 2003 Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144: 544-551
15. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RF, Smith RG, Van Der Floeg LH, Howard AD, MacNeil DJ, Qian S 2004 Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y (NPY) and agouti-related protein (AgRP). Endocrinology 145:2607-2612
16. Clark JT, Kalra FS, Crowley WR, Kalra SP 1984 Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115: 427-429
17. Hagan MM, Rushing FA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg LH, Woods SC, Seeley RJ 2000 Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol 279:R47-R52
18. Tang-Christensen M, Vrang N, Larsen FJ 1998 Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes 47:530-537
19. Mokdad AH, Marks JS, Stroup DF, Gerberding JL 2004 Actual causes of death in the United States, 2000. JAMA 291:1238-1245
20. Saris WH, Blair SN, van Baak MA, Eaton SB, Davies PS, Di Pietro L, Fogelholm M, Rissanen A, Schoeller D, Swinburn B, Tremblay A, Westerterp KR, Wyatt H 2003 How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev 4:101-114
21. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esteman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL 2003 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661
22. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR 2000 The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328
23. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
24. Stanley BG, Leibowitz SF 1984 Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35:2635-2642
25. Rosicka M, Krsek M, Jarkovska Z, Marek J, Schreiber V 2002 Ghrelin - a new endogenous growth hormone secretagogue. Physiol Res 51:435-441
26. Willesen MG, Kristensen P, Romer J 1999 Co-localization of growth hormone secretagogue receptor and NFV mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70:306-316
27. Luckman SM, Rosenzweig I, Dickson SL 1999 Activation of arcuate nucleus neurons by systemic administration of leptin and growth hormone-releasing peptide-6 in normal and fasted rats. Neuroendocrinology 70:93-100
28. Hewson AK, Dickson SL 2000 Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol 12:1047-1049
29. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I 2001 Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats. Diabetes 50: 2438-2443
30. Heilig M, Murison R 1987 Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 19:221-231
31. Heilig M, Wahlestedt C, Widerlov E 1988 Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors. Eur J Pharmacol 157:205-213
32. Jolicoeur FB, Bouali SM, Michaud JN, Menard D, Fournier A, St. Pierre S 1995 Structure-activity analysis of the motor effects of neuropeptide Y. Brain Res Bull 37:1-4
33. Pedrazzini T, Seydoux J, Kunstner P, Aubert JF, Grouzmann E, Beermann F, Brunner HR 1998 Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4:722-726
34. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD 1994 Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298-1308
35. Segal-Lieberman G, Bradley RL, Kokkotou E, Carlson M, Trombly DJ, Wang X, Bates S, Myers Jr MG, Flier JS, Maratos-Flier E 2003 Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci USA 100:10085-10090
36. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS 2002 Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 8:643-644
37. Haqq AM, Farooqi IS, O'Rahilly S, Stadlet DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ 2003 Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 88:174-178
38. DelParigi A, Tschop M, Heiman ML, Salbe AD, Vozarova B, Sell SM, Bunt JC, Tataranni PA 2002 High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 87:5461-5464
39. Eiholzer U, Nordmann Y, l'Allemand D, Schlumpf M, Schmid S, Kromeyer-Hauschild K 2003 Improving body composition and physical activity in Prader-Willi Syndrome. J Pediatr 142:73-78
40. Burman P, Ritzen EM, Lindgren AC 2001 Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 22:787-799
41. Levine JA, Eberhardt NL, Jensen MD 1999 Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283:212-214